The use of nanotechnology in cardiovascular disease

Meera Chandarana, Anthony Curtis, Clare Hoskins

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Cardiovascular diseases claim a number of lives globally; many of which are preventable. With the increase in diets that consist of high saturated fat, salt, and sugar, people often living sedentary lifestyles, and a rise in cases of obesity, the incidence of cardiovascular disease is increasing. These contributing factors, coupled with more advanced methods of diagnosis, have delivered statistics that clearly show that there is a rising trend in the prevalence of cardiovascular disease. Treatment for cardiovascular diseases is limited currently to oral medicines or invasive surgery. There is a huge gap in this area of medicine for novel therapeutics for improved patient outcomes. Nanotechnology may provide a solution to more effective treatment of disease, with better prognoses and a reduced side effect profile. This review will explore for potential solutions to the limited pharmacological therapies currently on the market and the future that lies ahead for the place of nanotechnology within cardiovascular medicine.
Original languageEnglish
Pages (from-to)1607–1619
Number of pages13
JournalApplied Nanoscience
Volume8
Issue number7
DOIs
Publication statusPublished - 16 Aug 2018

Fingerprint

Nanotechnology
Cardiovascular Diseases
Medicine
Sedentary Lifestyle
Oral Medicine
Therapeutics
Obesity
Salts
Fats
Pharmacology
Diet
Incidence

Keywords

  • nanomedicine
  • medical therapeutics
  • nanotechnology
  • cardiovascular disease

Cite this

Chandarana, M., Curtis, A., & Hoskins, C. (2018). The use of nanotechnology in cardiovascular disease. Applied Nanoscience, 8(7), 1607–1619. https://doi.org/10.1007/s13204-018-0856-z
Chandarana, Meera ; Curtis, Anthony ; Hoskins, Clare. / The use of nanotechnology in cardiovascular disease. In: Applied Nanoscience. 2018 ; Vol. 8, No. 7. pp. 1607–1619.
@article{04f0f6e3672849e2b1e4edf6ceb384c6,
title = "The use of nanotechnology in cardiovascular disease",
abstract = "Cardiovascular diseases claim a number of lives globally; many of which are preventable. With the increase in diets that consist of high saturated fat, salt, and sugar, people often living sedentary lifestyles, and a rise in cases of obesity, the incidence of cardiovascular disease is increasing. These contributing factors, coupled with more advanced methods of diagnosis, have delivered statistics that clearly show that there is a rising trend in the prevalence of cardiovascular disease. Treatment for cardiovascular diseases is limited currently to oral medicines or invasive surgery. There is a huge gap in this area of medicine for novel therapeutics for improved patient outcomes. Nanotechnology may provide a solution to more effective treatment of disease, with better prognoses and a reduced side effect profile. This review will explore for potential solutions to the limited pharmacological therapies currently on the market and the future that lies ahead for the place of nanotechnology within cardiovascular medicine.",
keywords = "nanomedicine, medical therapeutics, nanotechnology, cardiovascular disease",
author = "Meera Chandarana and Anthony Curtis and Clare Hoskins",
year = "2018",
month = "8",
day = "16",
doi = "10.1007/s13204-018-0856-z",
language = "English",
volume = "8",
pages = "1607–1619",
number = "7",

}

Chandarana, M, Curtis, A & Hoskins, C 2018, 'The use of nanotechnology in cardiovascular disease', Applied Nanoscience, vol. 8, no. 7, pp. 1607–1619. https://doi.org/10.1007/s13204-018-0856-z

The use of nanotechnology in cardiovascular disease. / Chandarana, Meera ; Curtis, Anthony; Hoskins, Clare.

In: Applied Nanoscience, Vol. 8, No. 7, 16.08.2018, p. 1607–1619.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The use of nanotechnology in cardiovascular disease

AU - Chandarana, Meera

AU - Curtis, Anthony

AU - Hoskins, Clare

PY - 2018/8/16

Y1 - 2018/8/16

N2 - Cardiovascular diseases claim a number of lives globally; many of which are preventable. With the increase in diets that consist of high saturated fat, salt, and sugar, people often living sedentary lifestyles, and a rise in cases of obesity, the incidence of cardiovascular disease is increasing. These contributing factors, coupled with more advanced methods of diagnosis, have delivered statistics that clearly show that there is a rising trend in the prevalence of cardiovascular disease. Treatment for cardiovascular diseases is limited currently to oral medicines or invasive surgery. There is a huge gap in this area of medicine for novel therapeutics for improved patient outcomes. Nanotechnology may provide a solution to more effective treatment of disease, with better prognoses and a reduced side effect profile. This review will explore for potential solutions to the limited pharmacological therapies currently on the market and the future that lies ahead for the place of nanotechnology within cardiovascular medicine.

AB - Cardiovascular diseases claim a number of lives globally; many of which are preventable. With the increase in diets that consist of high saturated fat, salt, and sugar, people often living sedentary lifestyles, and a rise in cases of obesity, the incidence of cardiovascular disease is increasing. These contributing factors, coupled with more advanced methods of diagnosis, have delivered statistics that clearly show that there is a rising trend in the prevalence of cardiovascular disease. Treatment for cardiovascular diseases is limited currently to oral medicines or invasive surgery. There is a huge gap in this area of medicine for novel therapeutics for improved patient outcomes. Nanotechnology may provide a solution to more effective treatment of disease, with better prognoses and a reduced side effect profile. This review will explore for potential solutions to the limited pharmacological therapies currently on the market and the future that lies ahead for the place of nanotechnology within cardiovascular medicine.

KW - nanomedicine

KW - medical therapeutics

KW - nanotechnology

KW - cardiovascular disease

U2 - 10.1007/s13204-018-0856-z

DO - 10.1007/s13204-018-0856-z

M3 - Review article

VL - 8

SP - 1607

EP - 1619

IS - 7

ER -

Chandarana M, Curtis A, Hoskins C. The use of nanotechnology in cardiovascular disease. Applied Nanoscience. 2018 Aug 16;8(7):1607–1619. https://doi.org/10.1007/s13204-018-0856-z